We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Certain Optic Cells Export Their Damaged Mitochondria for Destruction Elsewhere

By LabMedica International staff writers
Posted on 25 Jun 2014
Print article
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
A recent paper revealed that certain cells in the eye transfer damaged mitochondria to neighboring cells for destruction (mitophagy) and recycling.

Mitophagy is considered a subset of the process known as autophagy, by which damaged organelles are enwrapped and delivered to lysosomes for degradation. As such, it was always assumed that a cell degraded its own mitochondria. However, results presented in the June 16, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) by investigators at the University of California, San Diego (USA) and Johns Hopkins University (Baltimore, MD, USA) suggest that this assumption may be incorrect.

The investigators used advanced electron microscopy and molecular staining techniques to show that in the optic nerve head, large numbers of mitochondria were shed from neurons to be degraded by the lysosomes of adjoining glial cells. This investigation had been prompted by findings from a glaucoma mouse model that protein products from the retina were accumulating in the optic nerve head just behind the eye.

In the study, a virally introduced tandem fluorophore protein reporter of acidified mitochondria was introduced into mice retinal ganglion cells. The reporter revealed that acidified axonal mitochondria originating from the retinal ganglion cells became associated with lysosomes within columns of astrocytes in the optic nerve head. According to this reporter, a greater proportion of retinal ganglion cell mitochondria were degraded at the optic nerve head than in the ganglions. The investigators coined the term "transmitophagy" to describe this phenomenon.

“It does call into question the conventional assumption that cells necessarily degrade their own organelles. We do not yet know how generalized this process is throughout the brain, but our work suggests it is probably widespread,” said co-senior author Dr. Mark H. Ellisman, professor of neurosciences at the University of California, San Diego. “Mitochondria play prominent roles in the health of axons, which are fundamental to connecting neurons and transmitting information. It should be a priority to further explore what happens in transmitophagy and whether defects in this phenomenon contribute to neuronal dysfunction or disease.”

“The discovery of a standard process for transfer of trash from neuron to glia will most likely be very important to understanding age-related declines in function of the brain and neurodegenerative or metabolic disorders,” said co-senior author Dr. Nicholas Marsh-Armstrong, assistant professor of ophthalmology and neuroscience at Johns Hopkins University. “We expect the impact to be significant in other areas of biomedicine as well.”

Related Links:

University of California, San Diego
Johns Hopkins University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more